Eli Lilly announced on Wednesday that it has initiated six lawsuits against wellness vendors. These vendors are allegedly selling unauthorized versions of its experimental weight-loss drug, retatrutide. The company aims to curb the rising tide of illegal online sales of this potent drug.
A vial of Retatrutide photographed in Brooklyn, New York, highlights the ongoing issue. According to Eli Lilly, the unauthorized distribution of retatrutide by these vendors constitutes a significant problem, prompting the legal action.
Increased Funding Needed for Psychiatric Hospitals 
Trump Administration Distributes ACA Refund Checks 
Higher Consumption of Ultra-Processed Foods Linked to Increased Health Risks 
Understanding Inflammation: Myths and Facts 
Calm Parenting: Strategies to Manage Stress 
Trump’s Executive Order to Combat Mosquitoes and Ticks in D.C.